Advertisement
Screener

USANA HEALTH SCIENCES, INC. (USNA) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

1.5 / 5 stars · 32/110 Roast Me

USANA HEALTH SCIENCES, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

USANA HEALTH SCIENCES, INC. (USNA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $116.06 per share for the 12-month period ending 2019-12-28, per its 10-K filed 2020-02-25.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2020-02-25

  • USANA HEALTH SCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2015-04-04 was $102.10, a 77.20% increase year-over-year.
  • USANA HEALTH SCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2014-03-29 was $57.62.
  • USANA HEALTH SCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2019 was $116.06.
  • USANA HEALTH SCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2016 was $63.16, a 53.36% decline from fiscal 2016.
  • USANA HEALTH SCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2016 was $135.41, a 123.41% increase from fiscal 2015.
  • USANA HEALTH SCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2015 was $60.61, a 12.60% increase from fiscal 2013.
Period endShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month
2019-12-28$116.06
10-K · filed 2020-02-25
2016-12-31$63.16
10-K · filed 2017-03-01
2016-01-02$135.41
10-K · filed 2016-03-01
2015-10-03$135.97
10-Q · filed 2015-11-12
2015-07-04$105.27
10-Q · filed 2015-08-12
2015-04-04$102.10
10-Q · filed 2015-05-13
2015-01-03$60.61
10-K · filed 2015-03-17
2014-09-27$58.04
10-Q · filed 2014-11-06
2014-06-28$57.62
10-Q · filed 2014-08-05
2014-03-29$57.62
10-Q · filed 2014-05-07
2013-12-28$53.83
10-K · filed 2014-03-13
2012-12-29$39.41
10-K · filed 2013-03-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
Canopy Growth Corp (CGC)$0.395B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87